Martingale Asset Management L P boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 141,686 shares of the company's stock after acquiring an additional 2,138 shares during the quarter. Martingale Asset Management L P owned 0.06% of Cardinal Health worth $16,757,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of CAH. Mirae Asset Global Investments Co. Ltd. grew its holdings in Cardinal Health by 35.2% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company's stock worth $3,871,000 after purchasing an additional 8,471 shares during the period. CHURCHILL MANAGEMENT Corp raised its stake in Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock valued at $28,435,000 after acquiring an additional 3,576 shares during the period. Geode Capital Management LLC lifted its holdings in Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Consolidated Planning Corp boosted its position in Cardinal Health by 40.0% during the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company's stock worth $1,056,000 after purchasing an additional 2,552 shares during the period. Finally, Flputnam Investment Management Co. increased its holdings in shares of Cardinal Health by 1.8% in the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock valued at $21,358,000 after purchasing an additional 3,148 shares during the last quarter. Institutional investors own 87.17% of the company's stock.
Cardinal Health Price Performance
Shares of CAH stock traded up $1.26 on Monday, hitting $133.03. 332,028 shares of the company's stock were exchanged, compared to its average volume of 2,174,878. Cardinal Health, Inc. has a 12 month low of $93.17 and a 12 month high of $139.50. The company has a 50 day moving average of $129.33 and a 200 day moving average of $122.48. The stock has a market cap of $32.14 billion, a P/E ratio of 24.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's payout ratio is 37.69%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on CAH shares. Citigroup upped their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research note on Friday, January 10th. TD Cowen raised Cardinal Health from a "hold" rating to a "buy" rating and lifted their price target for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Jefferies Financial Group upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Bank of America boosted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a research report on Friday. Finally, Morgan Stanley lifted their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research note on Friday, January 31st. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and an average target price of $140.86.
Read Our Latest Report on CAH
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
